Related Experiment Videos
CRF facilitates NE release from the hippocampus: a microdialysis study
1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC.
Neuroscience Research
|May 1, 1994
Summary
Corticotropin-releasing factor (CRF) at moderate doses increases norepinephrine release and locomotor activity in rats. However, high doses of CRF decrease both, suggesting complex dose-dependent effects.
Area of Science:
- Neuroscience
- Neuroendocrinology
- Behavioral Pharmacology
Background:
- Corticotropin-releasing factor (CRF) is a key regulator of the stress response.
- Its role in modulating neurotransmitter release and behavior is complex and dose-dependent.
Purpose of the Study:
- To investigate the effects of different doses of CRF on norepinephrine (NE) release in the rat hippocampus.
- To examine the relationship between CRF administration, NE release, and locomotor activity.
Main Methods:
- In vivo microdialysis technique in rats.
- Administration of varying doses of CRF (1.44, 3.6, 7.2, and 14.4 micrograms).
- Measurement of norepinephrine release in the dentate gyrus of the hippocampus.
- Assessment of locomotor activity.
Main Results:
- Moderate doses of CRF (1.44–7.2 micrograms) significantly enhanced NE release in the hippocampus and increased locomotor activity.
- The highest dose of CRF (14.4 micrograms) paradoxically decreased NE release and reduced locomotor activity.
- A clear dose-response relationship was observed, with a biphasic effect of CRF.
Conclusions:
- CRF exhibits a dose-dependent, biphasic effect on norepinephrine release and locomotor activity in rats.
- These findings highlight intricate neuropeptide-neurotransmitter interactions with potential physiological significance in stress and behavior regulation.